LVLU entered its Q1 2026 earnings release with one of the more striking disconnects in recent micro-cap history: short sellers had quietly fled ahead of the print, yet the report delivered exactly the kind of result that might have justified their presence all along.
The numbers that landed after the close on May 13 were bleak. Q1 EPS came in at -$1.44, against a consensus estimate of -$0.12 — a miss of more than $1.30 per share. Revenue of $57.5 million fell well short of the $64.2 million the Street had pencilled in. The stock was already down 8.6% on the week before the print hit; the reaction to that magnitude of miss will define the next session. Earnings reaction data from the prior print — a March 30 release — showed only a 0.4% one-day move but a brutal -17.9% slide over the subsequent five days, a pattern worth keeping in mind.
The borrow market tells a story that cuts against the bearish fundamental picture. Short interest actually collapsed 42% over the past week to 1.14% of free float — roughly 14,000 shares — after peaking near 2.5% of float on April 29. That peak-to-trough unwind was swift and deliberate: estimated shorts dropped from around 30,500 shares to just 14,000 in a fortnight, leaving short interest at one of its lowest levels in the 45-day window. Despite that, the cost to borrow at 237% annually is extraordinary for a name with this little short interest — a function of the stock's tiny float and thin lending pool rather than any crowded-short dynamic. Borrow availability has been easing in the same direction as the cost-to-borrow retreat, with CTB down 21% over the past month from levels above 300% seen in late March and early April. The ORTEX short score is 44.6, down from 50.4 on April 29, moving in lockstep with the short interest reduction.
The ownership picture underscores just how concentrated and illiquid this stock is. H.I.G. Growth Partners holds roughly 32% of shares, and Canada Pension Plan Investment Board another 17.5%. Together, those two positions account for nearly half the company. With a market cap of only around $27 million, any meaningful position change moves the stock materially. Recent insider activity from March 31 shows CFO Crystal Landsem selling 4,549 shares at $12.72 — a price that looks distant from today's $9.30 close — though the dollar value ($57,863) was small and the trade significance score registered at the minimum level of 1. The net insider position over 90 days shows net selling of around 18,000 shares worth roughly $165,000.
With Q2 earnings currently scheduled for June 9, the next data point arrives quickly. The RSI of 39.8 reflects a market that has already been pricing in weakness, and the 78% year-to-date gain through early May means there was a meaningful move to give back even before the miss. What the market will now focus on is whether the Q1 revenue shortfall — $6.7 million against consensus — reflects a deteriorating demand backdrop for the brand, a one-off supply or timing issue, or something structural that a Q2 guide might begin to clarify.
See the live data behind this article on ORTEX.
Open LVLU on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
